慢性病急性并发症的门诊干预:范围综述及对CKD患者的启示
本范围综述检索至2019年12月,纳入77项研究(25项RCT),描述57种门诊干预措施,用于管理慢性病急性并发症。干预类型包括家庭医院、观察单元、急诊专科服务、门诊项目和远程监测,多数在慢性呼吸和心血管疾病中研究,无一项针对CKD人群。多数干预显示成本节约,但其他结局改善不一致,提示可改编并测试于CKD患者。
要点
- 慢性病急性并发症的门诊干预多样,但无针对CKD人群的研究。
- 多数干预显示成本节约,其他结局改善不一致。
- CKD患者急诊和住院率高,门诊干预或可替代急诊和住院护理。
核心结论
- 识别了多种慢性病急性并发症的门诊干预措施,但无一项针对CKD人群,其特征可改编并测试以满足CKD患者的复杂急性护理需求。
研究设计与样本
- 范围综述,检索MEDLINE、EMBASE、CINAHL、Cochrane CENTRAL、灰色文献和会议摘要至2019年12月,纳入77项研究(25项RCT、29项观察性、12项非对照前后、5项准实验、4项定性、2项混合方法),描述57种独特干预。
主要发现
- 干预类型包括家庭医院(n=16)、观察单元(n=9)、急诊专科服务(n=4)、门诊项目(n=18)和远程监测(n=10),多数在慢性呼吸和心血管疾病人群中研究。
- 无干预针对CKD人群。
- 多数干预显示成本节约,但其他结局领域的改善不一致。
临床怎么用
- CKD患者急诊和住院率高,门诊干预或可提供替代急诊和住院护理的选择。
- 现有干预措施的特征可改编并测试于CKD人群,以满足其复杂急性护理需求。
局限性
- 纳入研究异质性大。
- 缺乏CKD相关急性并发症的门诊干预数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Patients with chronic kidney disease (CKD) have high rates of emergency department (ED) use and hospitalization. Outpatient care may provide an alternative to ED and inpatient care in this population. We aimed to explore the scope of outpatient interventions used to manage acute complications of chronic diseases and highlight opportunities to adapt and test interventions in the CKD population. STUDY DESIGN: Scoping review of quantitative and qualitative studies. SETTING & POPULATION: Outpatient interventions for adults experiencing acute complications related to 1 of 5 eligible chronic diseases (ie, CKD, chronic respiratory disease, cardiovascular disease, cancer, and diabetes). SELECTION CRITERIA FOR STUDIES: MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, grey literature, and conference abstracts were searched to December 2019. DATA EXTRACTION: Intervention and study characteristics were extracted using standardized tools. ANALYTICAL APPROACH: Quantitative data were summarized descriptively; qualitative data were summarized thematically. Our approach observed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) extension for scoping reviews. RESULTS: 77 studies (25 randomized controlled trials, 29 observational, 12 uncontrolled before-after, 5 quasi-experimental, 4 qualitative, and 2 mixed method) describing 57 unique interventions were included. Of identified intervention types (hospital at home [n = 16], observation unit [n = 9], ED-based specialist service [n = 4], ambulatory program [n = 18], and telemonitoring [n = 10]), most were studied in chronic respiratory and cardiovascular disease populations. None targeted the CKD population. Interventions were delivered in the home, ED, hospital, and ambulatory setting by a variety of health care providers. Cost savings were demonstrated for most interventions, although improvements in other outcome domains were not consistently observed. LIMITATIONS: Heterogeneity of included studies; lack of data for outpatient interventions for acute complications related to CKD. CONCLUSIONS: Several interventions for outpatient management of acute complications of chronic disease were identified. Although none was specific to the CKD population, features could be adapted and tested to address the complex acute-care needs of patients with CKD.
引用
- Elliott MJ, Love S, Donald M, et al. Outpatient Interventions for Managing Acute Complications of Chronic Diseases: A Scoping Review and Implications for Patients With CKD. Am J Kidney Dis. 2020. PMID: 32479925. doi:10.1053/j.ajkd.2020.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。